Caltius Equity Partners

Caltius Equity Partners is a private equity firm based in Los Angeles, California, founded in 1999. As the equity arm of Caltius Capital Management, it specializes in investing in lower middle market companies through various strategies, including buyouts, growth capital, recapitalizations, and corporate divestitures. The firm focuses on sectors such as business and industrial services, information technology, and consumer services. By collaborating closely with management teams, Caltius aims to foster growth and drive value in its portfolio companies. As a Registered Investment Adviser, Caltius Equity Partners is committed to maintaining high standards of professionalism and integrity in its investment practices.

5 past transactions

Walker Edison

Venture Round in 2016
Walker Edison partner and a drop-ship solution for the biggest names in e-commerce. We are a data centric organization that is committed to deliver more than just innovative furniture - we are committed to help our customers Live Outside the Box™. Walker Edison is a global organization with operations in Brazil, Asia, the UK and Germany.

MC Group

Acquisition in 2015
MC Sign Company was founded in 1953 in Ashtabula, Ohio where it served Northeast Ohio and Western Pennsylvania in sign sales, manufacturing, service, and installation. At the time it was just a small business operated out of a garage in the area. In 1994, at age 24, Tim Eippert purchased MC Sign Company and envisioned an innovative growth strategy that expanded the operation to a national level. The company steadily grew from a traditional sign company to a leader in the industry providing national brand management, sign design, manufacturing, installation, program management, service and maintenance.

Vision Internet

Venture Round in 2014
Headquartered in El Segundo, Calif., Vision is a national leader in government website design, development and hosting with more than 700 government, non-profit and education clients in U.S. and Canadian communities with populations that range from less than 1,000 residents to more than 5 million. For more than 20 years, Vision has created cost-effective solutions that increase government efficiency, build transparency and promote interactive communications with citizens. The company’s powerful, easy-to-use subscription-based content management system, visionLive™, keeps local government websites relevant and effective; and the new visionPulse™ community engagement platform enables local governments to gather feedback on important issues. In both 2016 and 2017, Vision was named to Government Technology magazine’s GovTech 100, a listing of leading companies developing innovative or disruptive offerings to improve or transform government. The company was also named a top 10 company serving local government by Engaging Local Government Leaders in its 2016 ELGL Choice Awards.

BrightHeart

Private Equity Round in 2008
BrightHeart is a national network that provides pet care solutions for specialty and emergency veterinary hospitals. The company also provides its doctors and staff with outstanding career advancement opportunities and promotes communication with referring veterinarians and seeks to increase public awareness of the quality options to pet owners for the medical diagnosis and treatment of pets.

Radiant Research

Venture Round in 2004
Radiant Research, Inc. is a comprehensive clinical research and development company serving the biopharmaceutical, medical device and consumer products industries for over 22 years. Radiant employs the skills of more than 500 clinical research professionals exclusively focused on providing professional, high quality study conduct and drug development services. With over 75 research sites and more than 100 Principal Investigators, incorporating both stand-alone facilities as well as physician based centers; they are the country’s largest wholly-owned network of clinical trial sites with fully integrated quality systems and a database of over 2.5 million participants. Radiant has conducted more than 14,000 clinical trials across a variety of therapeutic areas. Their centers all have DEA certification for schedule II-V drugs and have CLIA waivers or CLIA PPMP (Provider Performed Microscopy Procedures) certifications to accommodate on-site lab testing. Additionally, all centers are self-identified with the FDA in support of the new requirements related to the Generic Drug User Fee Amendment (GDUFA). Staff at all of their centers routinely complete GCP and Human Protections training, IATA certification and ongoing training in a multitude of continuing clinical research education topics. Training documentation can be provided upon request for any individual staff member.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.